Q32 Bio Inc. (QTTB)
$8.06-7.78%Close
SELLCRISIS · day 32
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $103M
- Beta
- -0.33
- P/E (TTM)
- 2.89
- Short % float
- 72.96%
- Days to cover
- 4.3
- SI change
- +23.8%
- 1W
- -0.62%
- 1M
- -26.12%
- vs SPY 1W
- -0.48%
- vs SPY 1M
- -28.63%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on QTTB?
- LOPJLB’s latest quantitative signal on Q32 Bio Inc. (QTTB) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is QTTB in?
- Q32 Bio Inc. (QTTB) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Q32 Bio Inc. (QTTB) do?
- Operating as a clinical-stage biotechnology firm, Q32 Bio Inc. is dedicated to developing biologic therapies aimed at re-establishing healthy immune equilibrium in patients across the United States suffering from autoimmune and inflammatory disorders stemming from dysfunctional immune responses. The company's primary investigational therapy, ADX-097, is a humanized anti-C3d monoclonal antibody …